Spectrophotometric and HPLC determination of secnidazole in pharmaceutical tablets

Department of Pharmaceutical Analytical Chemistry, Alexandria University, Al Iskandarīyah, Alexandria, Egypt
Journal of Pharmaceutical and Biomedical Analysis (Impact Factor: 2.98). 08/2000; 22(6):887-897. DOI: 10.1016/S0731-7085(99)00290-3

ABSTRACT Simple and accurate spectrophotometric and HPLC methods were developed for the determination of secnidazole in tablets dosage form. The first spectrophotometric method depends on the reduction of secnidazole molecule with zinc dust and hydrochloric acid followed by condensation with either p-dimethylaminobenzaldehyde or anisaldehyde to give colored chromogens having absorbance at 494 and 398 nm, respectively. The second method was based on the reaction of the drug with sodium nitroprusside in the presence or absence of hydroxylammonium hydrochloride. The formed colored chromogens were measured at 584 and 508 nm, respectively. The experimental conditions were optimized and Beer’s law was obeyed over the applicable concentration ranges. The application of HPLC procedures depended on using either a conventional or microbore reverse-phase (C18) column along with mobile phases consisting of water and methanol (30:70), at pH of 3.5. Both techniques were applied successfully for the analysis of secnidazole in tablets form. The results obtained from both procedures were statistically compared using the Student’s-t and F-variance ratio tests.

27 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: The degradation behaviour of secnidazole was investigated under different stress degradation (hydrolytic, oxidative, photolytic and thermal) conditions recommended by International Conference on Harmonisation (ICH) using HPLC and LC-MS. A stability-indicating HPLC method was developed that could separate drug from degradation products formed under various conditions. Secnidazole was found to degrade significantly in alkaline conditions, oxidative stress, and also in the presence of light. Mild degradation of the drug occurred in acidic and neutral conditions. The drug was stable to dry heat. Resolution of drug and the degradation products formed under different stress studies were successfully achieved on a C-18 column utilizing water-methanol in the ratio of 85:15 and at the detection wavelength of 310 nm. The method was validated with respect to linearity, precision (including intermediate precision), accuracy, selectivity and specificity.
    Journal of Pharmaceutical and Biomedical Analysis 12/2004; 36(4):769-75. DOI:10.1016/j.jpba.2004.08.008 · 2.98 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A rapid and sensitive spectrophotometric method is proposed for determination of Metronidazole and Secnidazole. The method depends on the reduction of Metronidazole and Secnidazole molecule with zinc dust and hydrochloric acid flowed by diazotization and coupling with b-naphtol to give red colored chromogens easily measured spectrophotometrically which has lmaxZ510 nm. The experimental conditions were optimized and Berr’s law was obeyed over the applicable concentration ranges. Both techniques were applied successfully to a wide variety of pharmaceutical preparations.
    Dyes and Pigments 01/2006; 70(3):259-262. DOI:10.1016/j.dyepig.2005.01.009 · 3.97 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A simple, accurate, precise and sensitive HPLC-UV method was developed for the determination of secnidazole in human plasma. Secnidazole and tinidazole (IS) were extracted from 0.2 mL of human plasma by ethyl acetate. Secnidazole was then separated by HPLC on a Diamond C(18) column and quantified by ultraviolet detection at 319 nm. The mobile phase consisted of acetonitrile-aqueous 5 mm sodium acetate (30:70, v/v) containing of 0.1% acetic acid adjusted to pH 4.0, and the flow rate was 1.0 mL/min. The low limit of quantification was 0.1 microg/mL. The method was linear over the concentration range 0.1-25.0 microg/mL (R(2) = 1.000). The recovery of secnidazole from human plasma ranged from 76.5 to 89.1%. Inter- and intra-assay precision ranged from 3.3 to 10.7%. Secnidazole in plasma was stable when stored at ambient temperature for 8 h, at -20 degrees C for 2 weeks and at -20 degrees C for three freeze-thaw cycles. The developed method was successfully applied to the pharmacokinetic and bioequivalence studies between test and reference secnidazole tablets following a single 500 mg oral dosage to 20 healthy volunteers of both genders. Pharmacokinetics parameters T(max), C(max), AUC(0-)t, AUC(0-infinity), T(1/2) were determined of both preparations. The analysis of variance (ANOVA) did not show any significant difference between the two preparations and 90% confidence intervals fell within the acceptable range for bioequivalence. It was concluded that the two secnidazole preparations are bioequivalence and may be used interchangeably.
    Biomedical Chromatography 03/2007; 21(3):304-9. DOI:10.1002/bmc.758 · 1.72 Impact Factor
Show more